Siagosido
Siagosido Uses, Dosage, Side Effects, Food Interaction and all others data.
Siagosido (Sygen, AGF 2) has been investigated for the treatment of Parkinson Disease. It is a naturally occurring substance in the nerve cell’s membrane that is thought to play a role in cell growth, development, and repair. Siagosido completed phase 2 trials for parkinson's disease (PD) treatment. Sygen appears to be beneficial in patients with severe spinal cord injury. Treatment results in a 52% decrease in mortality 48 hours after the induction of ischemia in gerbils by permanent unilateral ligation of the common carotid artery.
| Trade Name | Siagosido |
| Generic | Siagoside |
| Siagoside Other Names | Ganglioside GM1 lactone, Siagoside, Siagosido, Siagosidum |
| Type | |
| Formula | C73H129N3O30 |
| Weight | Average: 1528.826 Monoisotopic: 1527.866089766 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Siagosido
